SCHEMBL9987986

SCHEMBL9987986

CCc1cc[c]c(-c2ccccc2Cl)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.37
ALDH1A1 P00352 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GAA P10253 1/20 0.36
HSD11B1 P28845 1/20 0.35
HSP90AA1 P07900 1/20 0.35
CASP3 P42574 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
DCUN1D1 Q96GG9 1/20 0.34
DPP4 P27487 2/20 0.34
NR1H2 P55055 1/20 0.34
NR1H3 Q13133 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
HPGD P15428 2/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9988636 0.84 ALDH1A1 (0.37) L3MBTL1ALDH1A1TDP1HSP90AA1DCUN1D1
SCHEMBL9987892 0.78 HSD11B1 (0.42) ALDH1A1TDP1GAAHSD11B1HSP90AA1
SCHEMBL9988458 0.74 PDE2A (0.42) L3MBTL1ALDH1A1TDP1HSD11B1CASP3
SCHEMBL17034486 0.71 L3MBTL1 (0.48) L3MBTL1ALDH1A1TDP1GAAHSD11B1
SCHEMBL27293196 0.69 CYP1A2 (0.51) L3MBTL1ALDH1A1TDP1GAAHSP90AA1
SCHEMBL9987959 0.69 LMNA (0.43) L3MBTL1ALDH1A1GAACASP3SENP8
SCHEMBL1969571 0.67 DPP4 (0.41) ALDH1A1TDP1HSD11B1DPP4HPGD
SCHEMBL18015824 0.67 ALDH1A1 (0.73) L3MBTL1ALDH1A1TDP1GAAHPGD
SCHEMBL15636515 0.66 DPP4 (0.40) L3MBTL1ALDH1A1TDP1HSD11B1DPP4
SCHEMBL16770866 0.66 CASP3 (0.60) ALDH1A1CASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397462-A2 Compounds, compositions and methods of treatment for heart failure Cytokinetics, Inc. (US) 2011-12-21 EP claimed